We believe connecting human & artificial intelligence will revolutionize emergency care
At Nicolab, we connect the right physicians at the right time to streamline emergency workflows. By providing physicians with all necessary information at their fingertips, they can diagnose patients more accurately and make faster treatment decisions.
Connecting the right people at the right time with AI-analyzed patient scans and centralized patient information streamlines clinical care to prevent unnecessary delay to treatment, giving patients the best chances of living their normal life after the emergency department.
Nicolab was founded in 2015 following the acclaimed MR CLEAN trial, the first Randomised Clinical Trial proving the benefit of Endovascular Treatment. The trial led to a global paradigm shift in acute stroke care and triaging, resulting in the hospital Hub and Spoke model.
Leading MR CLEAN researchers and our co-founders, Dr. Merel Boers and Dr. Renan Sales Barros, recognized the need for an AI solution to revolutionize stroke care. With exclusive access to the heterogeneous MR CLEAN dataset, Nicolab developed StrokeViewer. StrokeViewer provides the most accurate AI algorithms to diagnose stroke patients worldwide.
Our background is steeped in leading clinical research, which is why we continue to invest and contribute significantly to research, ensuring that Nicolab remains at the forefront of driving innovative change and improving outcomes for stroke patients.
Our story today
While Nicolab continues to run its operations with Headquarters in Amsterdam, The Netherlands, we are proudly an Australian-based publicly unlisted company with an expanding global presence.
Our core values
We communicate openly and honestly about who we are and what we do and expect the same from our clients.
We lead the way in applying cutting-edge technology to help physicians improve emergency care.
We value feedback and discussion, and we are open-minded and focused on meeting our client’s needs.
Culture of Friendship
We establish long-lasting relationships based on trust and work together to make our clients successful.
Drive for performance
We are dedicated to empowering physicians to create a great impact and constantly improving ourselves.
Board of directors
Nicolab has an internationally experienced board that has held a large number of senior positions at both listed and unlisted companies.
Paul J. Lappin
Chair Paul J. Lappin is an experienced company director, chairman and chartered accountant (PWC Aust & Nth America), leading companies in a diverse range of sectors including the tourism, events, hospitality, biotechnology and commercial arenas.
Paul is a director of the Australian Grand Prix Corp, PGA Australia and former chairman of ASX listed Polynovo (PNV) (formerly Metabolic Pharmaceuticals Ltd).
Nico Klay, MD, MBA
Former chairman of Rotterdam Eye Hospital and founder of X-Infex, Nico Klay’s experience in the medical sector further strengthens the company’s expertise.
Bronwyn King AO, MD
Dr. Bronwyn King is a practicing Radiation Oncologist and is the current founder and CEO of Tobacco Free Portfolios.
Bronwyn is also a partner in Healthcare Ventures and a director of the Victorian Managed Insurance Authority.
She was the team doctor for the Australian Swimming team for 8 years.
Frans van Belle
Frans van Belle is an experienced business professional, having held several management positions within Philips and laid the foundation for KPN in London. Frans holds advisory positions in private equity and started the Exchange Company, which invests in Technology / IT, Healthcare, and E-Learning.
Partnering with leading health tech company Philips will enable us to bring our technology to more hospitals across the world and provide more patients with the care they deserve.
We are delighted to have a strategic partnership with a leading health technology company. We look forward to leveraging Philips’ years of experience in the stroke space and wide network to bring StrokeViewer to more hospitals across the globe.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.